CA3218824A1 - Stapled peptides and methods thereof - Google Patents
Stapled peptides and methods thereof Download PDFInfo
- Publication number
- CA3218824A1 CA3218824A1 CA3218824A CA3218824A CA3218824A1 CA 3218824 A1 CA3218824 A1 CA 3218824A1 CA 3218824 A CA3218824 A CA 3218824A CA 3218824 A CA3218824 A CA 3218824A CA 3218824 A1 CA3218824 A1 CA 3218824A1
- Authority
- CA
- Canada
- Prior art keywords
- agent
- independently
- group
- amino acid
- staple
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208487P | 2021-06-08 | 2021-06-08 | |
| US63/208,487 | 2021-06-08 | ||
| US202163224834P | 2021-07-22 | 2021-07-22 | |
| US63/224,834 | 2021-07-22 | ||
| US202263303952P | 2022-01-27 | 2022-01-27 | |
| US63/303,952 | 2022-01-27 | ||
| PCT/US2022/032738 WO2022261257A1 (en) | 2021-06-08 | 2022-06-08 | Stapled peptides and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3218824A1 true CA3218824A1 (en) | 2022-12-15 |
Family
ID=84425507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3218824A Pending CA3218824A1 (en) | 2021-06-08 | 2022-06-08 | Stapled peptides and methods thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240360179A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4355350A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024522368A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240031957A (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023025528A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3218824A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL308790A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023014679A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022261257A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020004555A2 (pt) | 2017-09-07 | 2020-09-24 | Fog Pharmaceuticals, Inc. | agentes que modulam funções de beta-catenina e métodos dos mesmos |
| AU2019326423A1 (en) | 2018-08-20 | 2021-04-08 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| US20260207704A1 (en) * | 2022-12-15 | 2026-07-23 | Parabilis Medicines, Inc. | Stapled peptides and methods thereof |
| WO2024130217A1 (en) * | 2022-12-15 | 2024-06-20 | Fog Pharmaceuticals, Inc. | Stapled peptides and methods thereof |
| WO2024130224A2 (en) * | 2022-12-16 | 2024-06-20 | Purdue Research Foundation | Stapled peptides for sensitization of cancer to treatment |
| JP2026520144A (ja) * | 2023-06-06 | 2026-06-22 | パラビリス メディシンズ, インコーポレイテッド | ステープルペプチドおよびその方法 |
| WO2025265097A1 (en) * | 2024-06-20 | 2025-12-26 | Parabilis Medicines, Inc. | Stapled peptides and methods thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2508531B1 (en) * | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| EP3549951A3 (en) * | 2008-12-09 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Methods and compositions for specific modulation of mcl-1 |
| WO2012040459A2 (en) * | 2010-09-22 | 2012-03-29 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| EP3782638A1 (en) * | 2013-03-13 | 2021-02-24 | President and Fellows of Harvard College | Stapled and stitched polypeptides and uses thereof |
| WO2016085280A1 (ko) * | 2014-11-28 | 2016-06-02 | 서울대학교산학협력단 | 세포 투과성 스테이플 펩타이드, 이의 제조방법 및 그 용도 |
| US10011631B2 (en) * | 2015-12-01 | 2018-07-03 | The University Of Hong Kong | Stapled helical peptides and methods of synthesis |
| BR112020004555A2 (pt) * | 2017-09-07 | 2020-09-24 | Fog Pharmaceuticals, Inc. | agentes que modulam funções de beta-catenina e métodos dos mesmos |
| CN111447941B (zh) * | 2017-10-27 | 2023-10-31 | 俄亥俄州国家创新基金会 | 用于细胞内递送装订肽的多肽缀合物 |
| AU2019326423A1 (en) * | 2018-08-20 | 2021-04-08 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| CA3186681A1 (en) * | 2020-07-22 | 2022-01-27 | Brian Halbert WHITE | Stapled peptides and methods thereof |
-
2022
- 2022-06-08 BR BR112023025528A patent/BR112023025528A2/pt unknown
- 2022-06-08 EP EP22820994.6A patent/EP4355350A4/en active Pending
- 2022-06-08 CA CA3218824A patent/CA3218824A1/en active Pending
- 2022-06-08 MX MX2023014679A patent/MX2023014679A/es unknown
- 2022-06-08 WO PCT/US2022/032738 patent/WO2022261257A1/en not_active Ceased
- 2022-06-08 JP JP2023575560A patent/JP2024522368A/ja active Pending
- 2022-06-08 KR KR1020237042998A patent/KR20240031957A/ko active Pending
- 2022-06-08 US US18/568,212 patent/US20240360179A1/en active Pending
- 2022-06-08 IL IL308790A patent/IL308790A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL308790A (en) | 2024-01-01 |
| JP2024522368A (ja) | 2024-06-18 |
| US20240360179A1 (en) | 2024-10-31 |
| BR112023025528A2 (pt) | 2024-02-27 |
| EP4355350A4 (en) | 2025-10-01 |
| WO2022261257A1 (en) | 2022-12-15 |
| EP4355350A1 (en) | 2024-04-24 |
| KR20240031957A (ko) | 2024-03-08 |
| MX2023014679A (es) | 2024-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024204726A1 (en) | TYK2 inhibitors and uses thereof | |
| CA3186681A1 (en) | Stapled peptides and methods thereof | |
| EP3578561A1 (en) | Spiro compounds | |
| JP6918378B2 (ja) | CaMKII阻害剤及びその使用 | |
| JP7428833B2 (ja) | ヒストン脱アセチル化酵素6阻害剤としての1,3,4-オキサジアゾール誘導体化合物、およびそれを含む医薬組成物 | |
| KR20240031957A (ko) | 스테이플화된 펩티드 및 이의 방법 | |
| CN105102450B (zh) | 作为PERK抑制剂的N‑(2,3‑二氢‑1H‑吡咯并[2,3‑b]吡啶‑5‑基)‑4‑喹唑啉胺和N‑(2,3‑二氢‑1H‑吲哚‑5‑基)‑4‑喹唑啉胺衍生物 | |
| JP2021505132A (ja) | 核酸結合光プローブおよびその使用 | |
| CA3083616A1 (en) | Myst family histone acetyltransferase inhibitors | |
| CN116283918B (zh) | 一种降解受体酪氨酸激酶的双功能化合物及其应用 | |
| WO2017184658A1 (en) | ACYL SULFONAMIDE NaV1.7 INHIBITORS | |
| EP2382215B1 (fr) | Dérivés de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur préparation et leur application en thérapeutique | |
| CN117769556A (zh) | 嘧啶并环类衍生物及其制备方法和用途 | |
| CN109641909A (zh) | 雷帕霉素信号通路抑制剂的机理靶标及其治疗应用 | |
| CN104804001B9 (zh) | 4-取代吡咯并[2,3-d]嘧啶化合物及其用途 | |
| CN119264065A (zh) | 一类细胞程序性坏死抑制剂及其制备方法和用途 | |
| CN110054577B (zh) | 一类含脲和硫脲结构的化合物、合成方法及其应用 | |
| CN109890823A (zh) | 稠合氮杂环化合物及其作为ampa受体调节剂的用途 | |
| CA2694994C (fr) | Derives de n-heteroaryl-carboxamides tricycliques, leur preparation et leur application en therapeutique | |
| CN110256346A (zh) | 具有brd4蛋白抑制作用的菲啶酮类化合物及制备方法和应用 | |
| CN113004284B (zh) | 作为血浆激肽释放酶抑制剂的四环类化合物及其用途 | |
| EP3556760A1 (en) | Spiro compounds | |
| KR100746939B1 (ko) | 염증억제 활성을 가지는n-[1'-치환술폰아미드-스파이로(2h-1-벤조피란-2,4-피페리딘)-6-일]치환아민 유도체, 그의 약학적으로허용가능한 염, 그의 제조방법 및 그의 용도 | |
| EA052562B1 (ru) | ИНГИБИТОРЫ PI3Kα И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| CN103570688B (zh) | 2,5-二氨甲基吡嗪类化合物、其药物组合物、制备方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R11-R103 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF NAME REQUEST RECEIVED Effective date: 20241105 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241105 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250530 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250530 |
|
| R13 | Change to the name of applicant or owner recorded |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R13-R104 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF NAME REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250618 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260513 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260601 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260601 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260608 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20260608 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260608 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260713 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260713 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260713 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260713 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260713 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260715 |